優必選科技將在北京亦莊成立行者天工機器人全資子公司
4月19日,由優必選科技作為大股東發起單位和總經理單位的北京人形機器人創新中心研製的“天工Ultra”在全球首個人形機器人半程馬拉松以2小時40分鐘的成績奪得冠軍!優必選科技同時宣佈,將在北京亦莊成立行者天工機器人全資子公司,負責行者(Walker)系列、天工系列及天工行者(科研教育版)等系列人形機器人的全面商業化及全球銷售。這是繼3月12日優必選科技和創新中心聯合推出全尺寸科研教育人形機器人平台——天工行者(定價29.9萬起,是業內首款30萬元以內的全尺寸科研級人形機器人)之後的又一重磅舉措。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.